glp-1 bowel obstruction class action in west virginia “Sulfur burps” patients on therapies may be more than a minor side effect. Experts note these symptoms can reflect underlying gastrointestinal changes linked to the drugs’ mechanism of GLP-1 Receptor Agonists in Gastrointestinal
Description
If youve read this far, youre ready to take action
If you are weighing that, treat it as one option within a wider strategy, and talk with your clinician or pharmacist before adding anything while on GLP-1 therapy
Cochrane, 2024
In this review I aim to re-examine the contested concept of food addiction as a disease in the context of emerging GLP-1based obesity pharmacotherapies, integrating perspectives from neurobiology, societal impacts, and early evidence for their potential application in other substance-use disorders
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice
